Quantum-Si incorporated
NASDAQ:QSIBiotechnology
+$0.05 today
- Market cap
- $213.79M
- Beta
- 3.17
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.48
Volume 10.47M
Average 5.64M
QSI Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Quantum-Si incorporatedNASDAQ: QSI
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin declines year over year
Q1 FY2026 selling, general & admin of $9.64M fell 18.9% year over year, behind the -16.5% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 6.1% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.
Context
- Selling, general & admin amounted to 1837.2% of revenue in FY2025, up 184.6 pp from a year earlier.
- Selling, general & admin increased in 2 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 2 analysts of $16.33M (-63.5%) for the fiscal year ending Dec 2026, a slowdown from the -11.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $9.64M-6.1% QoQ
- Last fiscal yearDec 2025
- $44.75M-11.4% YoY
- LTMMar 2026
- $42.51M-16.5% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 44.75M USD
- Year-over-year change
- -11.4%
- 4-year CAGR
- -2.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 44.75M | -11.4% |
| FY2024 | 2024-12-31 | 50.54M | +13.2% |
| FY2023 | 2023-12-31 | 44.63M | +5.5% |
| FY2022 | 2022-12-31 | 42.3M | -16.0% |
| FY2021 | 2021-12-31 | 50.33M | — |
Selling, General & Admin vs competitors
How QSI compares with its peers on the latest reported figures
- QSI's LTM Mar 2026 selling, general & admin of $42.51M is the 4th highest of the 11 companies compared; the peer median is $36.8M.
- Its year-over-year change of -16.5% is the 9th highest of 10, against a peer median of +18.8%.
- Selling, general & admin amounts to 2295.5% of revenue for QSI, versus a peer median of 153.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $142.24M | +17.3% | +60.5% | 153.6% | |
| LTM Mar 2026 | $82.03M | +32.5% | — | 103.6% | |
| LTM Mar 2026 | $75.11M | -30.1% | +13.7% | — | |
| LTM Mar 2026 | $42.51M | -16.5% | +1.9% | 2295.5% | |
| LTM Mar 2026 | $40.91M | +18.8% | +10.3% | — | |
| LTM Mar 2026 | $38.19M | +65.9% | +17.2% | — | |
ENGNenGene Holdings Inc. | LTM Apr 2026 | $35.41M | +41.6% | +106.4% | — |
| LTM Mar 2026 | $32.75M | -0.8% | +0.8% | — | |
| LTM Mar 2026 | $30.16M | +39.3% | +17.9% | 83769.4% | |
| LTM Mar 2026 | $23.71M | +3.3% | +7.6% | — | |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $18.21M | — | +110.6% | — |
| Peer median (excluding QSI) | $36.8M | +18.8% | +17.2% | 153.6% | |
Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1.08M | 3.06M | 2.44M |
| Cost of Revenue | 0 | 0 | 594K | 1.46M | 1.28M |
| Gross Profit | 0 | 0 | 488K | 1.6M | 1.15M |
| Gross Margin | — | — | 45.1% | 52.3% | 47.3% |
| Research & Development | 46.58M | 72.06M | 67.03M | 59.64M | 53.76M |
| Selling, General & Admin | 50.33M | 42.3M | 44.63M | 50.54M | 44.75M |
| Operating Expenses | 96.91M | 123.84M | 111.66M | 110.18M | 98.51M |
| Depreciation & Amortization | 1.04M | 2.58M | 4.16M | 4.6M | 4.45M |
| EBITDA | (93.94M) | (111.77M) | (91.8M) | (96.35M) | (96.83M) |
| EBITDA Margin | — | — | -8484.7% | -3150.8% | -3974.8% |
| Operating Income | (96.91M) | (123.84M) | (111.17M) | (108.58M) | (97.36M) |
| Operating Margin | — | — | -10274.6% | -3550.6% | -3996.7% |
| Interest Income | 0 | 0 | 0 | 0 | 8.96M |
| Interest Expense | 5K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.92M | (8.6M) | 15.21M | 7.63M | (3.92M) |
| Income Before Tax | (94.99M) | (132.44M) | (95.96M) | (100.95M) | (101.28M) |
| Pre-Tax Margin | — | — | -8868.8% | -3301.2% | -4157.7% |
| Income Tax Expense | 0 | 0 | 0 | 56K | 58K |
| Net Income | (94.99M) | (132.44M) | (95.96M) | (101.01M) | (101.34M) |
| Net Margin | — | — | -8868.8% | -3303.0% | -4160.1% |
| EPS (Basic) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| EPS (Diluted) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| Weighted Avg Shares | 79.58M | 139.26M | 141.3M | 143.2M | 197.77M |
| Weighted Avg Shares (Diluted) | 79.58M | 139.26M | 141.3M | 143.2M | 197.77M |
Quantum-Si incorporated
NASDAQ:QSI
Intrinsic Alpha fair value
Locked
Current Price
$1.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.